Soros Fund Management’s Chemours CC Stock Holding History

Soros Fund Management’s Portfolio CC Stock Details CC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q2	–	Sell	-112,348	Closed	-$2.95M	–	184
2024 Q1	$2.95M	Buy	+112,348	New	+$3.2M	0.05%	170
2017 Q3	–	Sell	-9,500	Closed	-$360K	–	238
2017 Q2	$360K	Buy	+9,500	New	+$375K	0.01%	152

Other funds holding CC

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

KCM

Khrom Capital Management Miami Beach, Florida $1.09B AUM 14.82% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

VNIM

Vaughan Nelson Investment Management Houston, Texas $11.3B AUM 53% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return

Soros Fund Management's CC Position: Q2 2024 in Review

Soros Fund Management sold out of Chemours (CC) in Q2 2024, closing a stake of 112,348 shares — an estimated $2.95M sold.

Soros Fund Management first reported a position in CC in Q2 2017 and held it in 2 quarters. The position peaked at $2.95M in Q1 2024. 435 funds tracked by Wall St. Rank hold CC as of Q2 2024.

Soros Fund Management reported no remaining Chemours position as of Q2 2024 after selling out during the quarter.
Soros Fund Management sold 112,348 Chemours shares in Q2 2024, an estimated $2.95M.
Soros Fund Management first reported a position in Chemours in Q2 2017 and held it in 2 quarters.
Soros Fund Management's Chemours position peaked at $2.95M in Q1 2024.
435 funds tracked by Wall St. Rank held Chemours as of Q2 2024.

Based on Soros Fund Management's 13F filing for Q2 2024, filed 14 Aug 2024.